UBS Group’s Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share GETR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,141
Closed 11408
2022
Q3
$0 Buy
6,141
+2,000
+48% +$212 ﹤0.01% 11289
2022
Q2
$0 Buy
4,141
+10
+0.2% +$3 ﹤0.01% 11288
2022
Q1
$2K Buy
4,131
+1,900
+85% +$1.06K ﹤0.01% 9730
2021
Q4
$2K Buy
2,231
+1,965
+739% +$1.87K ﹤0.01% 9869
2021
Q3
$0 Buy
+266
New +$281 ﹤0.01% 10316

Other funds holding GETR.WS

UBS Group's GETR.WS Position: Q4 2022 in Review

UBS Group sold out of Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (GETR.WS) in Q4 2022, closing a stake of 6,141 shares.

UBS Group first reported a position in GETR.WS in Q3 2021 and held it in 5 quarters. The position peaked at $2K in Q1 2022. 41 funds tracked by Wall St. Rank hold GETR.WS as of Q4 2022.

  • UBS Group reported no remaining Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 6,141 Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022.
  • UBS Group first reported a position in Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q3 2021 and held it in 5 quarters.
  • UBS Group's Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $2K in Q1 2022.
  • 41 funds tracked by Wall St. Rank held Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.